<p>Asthma: Beclomethasone dipropionate/Formoterol fumarate dihydrate is indicated in the regular treatment of asthma where use of a combination product (inhaled corticosteroid and long-acting &beta;2-agonist) is appropriate: patients not adequately controlled with inhaled corticosteroids and &#39;as needed&#39; inhaled rapid-acting &beta;2-agonist or patients already adequately controlled on both inhaled corticosteroids and long-acting &beta;2-agonists.<br />
<br />
COPD:&nbsp;Symptomatic treatment of patients with severe COPD (FEV1&nbsp;&lt;50% predicted normal) and a history of repeated exacerbations, who have significant symptoms despite regular therapy with long-acting bronchodilators.</p>